Top

Surgery Today

Published in:

01-12-2015 | Original Article

Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size

Authors: Hiroaki Nomori, Yue Cong, Hiroshi Sugimura, Yoshiaki Kato

Published in: Surgery Today | Issue 12/2015

Abstract

Purposes

To examine whether diffusion-weighted magnetic resonance imaging (DWI) is as useful as fluorodeoxyglucose positron emission tomography (FDG-PET) for discriminating between malignant and benign pulmonary nodules measuring less than 3 cm in size, as well as for predicting tumor aggressiveness.

Methods

PET and DWI were carried out on 87 pulmonary nodules measuring from 1 to 3 cm in size (66 NSCLCs and 21 benign nodules). The signal intensity (SI) of DWI was measured by the contrast ratio (CR) between the lesions and spinal cord, i.e. SI-CR. The maximum standard uptake value (SUV) of PET was measured by CR between the lesions and contralateral lung, i.e. SUV-CR.

Results

DWI and PET showed sensitivities of 0.86 and 0.71, and specificities of 0.90 and 0.81, respectively. While there was no significant difference in the specificity between the two, DWI showed a significantly higher sensitivity than PET (p = 0.013). While the difference in the sensitivity was significant in lung adenocarcinoma (p = 0.012), there was no difference in the other histological types. Both the SI-CR and SUV-CR were significantly higher in the tumors with either histological invasiveness or lymphatic metastasis than in those without.

Conclusions

DWI is thus considered to be useful, not only to diagnose NSCLCs, especially in lung adenocarcinoma, but also for predicting tumor aggressiveness as well as FDG-PET.

Higashi K, Nishikawa T, Seki H, Oguchi M, Nambu Y, Ueda Y, Yuasa K, Tonami H, Okimura T, Yamamoto I. Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung cancer. J Nucl Med. 1998;39:1016–20.PubMed

Cheran SK, Nielsen ND, Patz EF Jr. False-negative findings for primary lung tumors on FDG positron emission tomography: staging and prognostic implications. AJR. 2004;182:1129–32.CrossRefPubMed

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Evaluation of F-18 fluorodeoxyglucose (FDG) PET scanning for pulmonary nodules less than 3 cm in diameter, with special reference to CT images. Lung Cancer. 2004;45:19–27.CrossRefPubMed

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Kobayashi T, Uno K. Fluorine 18-tagged fluorodeoxyglucose positron emission tomographic scanning to predict lymph node metastasis, invasiveness, or both, in clinical T1 N0 M0 lung adenocarcinoma. J Thorac Cardiovasc Surg. 2004;128:396–401.CrossRefPubMed

Watanabe K, Nomori H, Ohtsuka T, Naruke T, Ebihara A, Orikasa H, Yamazaki K, Uno K, Kobayashi T, Goya T. [F-18] Fluorodeoxyglucose positron emission tomography can predict pathological tumor stage and proliferative activity determined by Ki-67 in clinical stage IA lung adenocarcinomas. Jpn J Clin Oncol. 2006;36:403–9.CrossRefPubMed

Imai K, Minamiya Y, Saito H, Motoyama S, Sato Y, Ito A, Yoshino K, Kudo S, Takashima S, Kawaharada Y, Kurihara N, Orino K, Ogawa J. Diagnostic imaging in the preoperative management of lung cancer. Surg Today. 2014;44:1197–206.CrossRefPubMed

Goo JM, Im JG, Do KH, Yeo JS, Seo JB, Kim HY, Chung JK. Pulmonary tuberculoma evaluated by means of FDG PET: findings in 10 cases. Radiology. 2000;216:117–21.CrossRefPubMed

Wang J, Takashima S, Takayama F, Kawashima S, Saito A, Matsushita T, Momose M, Ishiyama T. Head and neck lesions: characterization with diffusion-weighted echo-planar MR imaging. Radiology. 2001;220:621–30.CrossRefPubMed

Sumi M, Takagi Y, Uetani M, Morikawa M, Hayashi K, Kabasawa H, Aikawa K, Nakamura T. Diffusion-weighted echoplanar MR imaging of salivary glands. AJR. 2002;178:959–65.CrossRefPubMed

10.

Takahara T, Imai Y, Yamashita T, Yasuda S, Nasu S, Van Cauteren M. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): technical improvement using free breathing, STIR and high resolution 3D display. Rad Med. 2004;22:275–82.

11.

Nasu K, Kuroki Y, Kuroki S, Murakami K, Nawano S, Moriyama N. Diffusion-weighted single shot echo planar imaging of colorectal cancer using a sensitivity-encoding technique. Jpn J Clin Oncol. 2004;34:620–6.CrossRefPubMed

12.

Murakami R, Sugahara T, Nakamura H, Hirai T, Kitajima M, Hayashida Y, Baba Y, Oya N, Kuratsu J, Yamashita Y. Malignant supratentorial astrocytoma treated with postoperative radiation therapy: prognostic value of pretreatment quantitative diffusion-weighted MR imaging. Radiology. 2007;243:493–9.CrossRefPubMed

13.

Woodhams R, Matsunaga K, Kan S, Hata H, Ozaki M, Iwabuchi K, Kuranami M, Watanabe M, Hayakawa K. ADC mapping of benign and malignant breast tumors. Magn Reson Med Sci. 2005;4:35–42.CrossRefPubMed

14.

Hayashida Y, Yakushiji T, Awai K, Katahira K, Nakayama Y, Shimomura O, Kitajima M, Hirai T, Yamashita Y, Mizuta H. Monitoring therapeutic responses of primary bone tumors by diffusion-weighted image: initial results. Eur Radiol. 2006;16:2637–43.CrossRefPubMed

15.

Reinsberg SA, Payne GS, Riches SF, Ashley S, Brewster JM, Morgan VA, deSouza NM. Combined use of Diffusion-Weighted MRI and 1H MR Spectroscopy to Increase Accuracy in Prostate Cancer Detection. AJR. 2007;188:91–8.CrossRefPubMed

16.

Dzik-Jurasz A, Domenig C, George M, Wolber J, Padhani A, Brown G, Doran S. Diffusion MRI for prediction of response of rectal cancer to chemoradiation. Lancet. 2002;360:307–8.CrossRefPubMed

17.

Matoba M, Tonami H, Kondou T, Yokota H, Higashi K, Toga H, Sakuma T. Lung carcinoma: diffusion weighted MR imaging—preliminary evaluation with apparent diffusion coefficient. Radiology. 2007;243:570–7.CrossRefPubMed

18.

Mori T, Nomori H, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y. Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol. 2008;3:358–64.CrossRefPubMed

19.

Ohba Y, Nomori H, Mori T, Ikeda K, Shibata H, Kobayashi H, Shiraishi S, Katahira K. Is diffusion-weighted magnetic resonance imaging superior to fluorodeoxyglucose-positron emission tomography in non-small cell lung cancer? J Thorac Cardiovasc Surg. 2009;138:439–45.CrossRefPubMed

20.

Nomori H, Mori T, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results. J Thorac Cardiovasc Surg. 2008;135:816–22.CrossRefPubMed

21.

Ohno Y, Koyama H, Onishi Y, Takenaka D, Nogami M, Yoshikawa T, Matsumoto S, Kotani Y, Sugimura K. Non-small cell lung cancer: whole-body MR examination for M-stage assessment—utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT. Radiology. 2008;248:643–54.CrossRefPubMed

22.

Komori T, Narabayashi I, Matsumura K, Matsuki M, Akagai H, Ogura Y, Aga F, Adachi I. 2-[Fluorine-18]-fluoro-2-deoxy-d-glucose positron emission tomography/computed tomography versus whole-body diffusion-weighted MRI for detection of malignant lesions: initial experience. Ann Nucl Med. 2007;21:209–15.CrossRefPubMed

23.

Lichy MP, Aschoff P, Plathow C, Stemmer A, Horger W, Mueller W, Steidle G, Horger M, Schafer J, Eschmann SM, Kiefer B, Claussen CD, Pfannenberg C, Schlemmer HP. Tumor detection by diffusion-weighted MRI and ADC-mapping—initial clinical experiences in comparison to PET-CT. Invest Radiol. 2007;42:605–13.CrossRefPubMed

24.

Uto T, Takehara Y, Nakamura Y, Naito T, Hashimoto D, Inui N, Suda T, Nakamura H, Chida K. Higher sensitivity and specificity for diffusion-weighted imaging of malignant lung lesions without apparent diffusion coefficient quantification. Radiology. 2009;252:247–54.CrossRefPubMed

25.

Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann Thorac Surg. 2005;79:984–8.CrossRefPubMed

26.

Ohba Y, Nomori H, Shibata H, Kobayashi H, Mori T, Shiraishi S, Nakashima R. Evaluation of visual and semiquantitative assessments of fluorodeoxyglucose-uptake on PET Scans for the diagnosis of pulmonary malignancies 1 to 3 cm in Size. Ann Thorac Surg. 2009;87:886–91.CrossRefPubMed

27.

Wang J, Takashima S, Takayama F, Kawakami S, Saito A, Matsushita T, Momose M, Ishiyama T. Head and neck lesions: characterization with diffusion weighted echo-planar MR imaging. Radiology. 2001;220:621–30.CrossRefPubMed

Title: Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size
Authors: Hiroaki Nomori
Yue Cong
Hiroshi Sugimura
Yoshiaki Kato
Publication date: 01-12-2015
Publisher: Springer Japan
Published in: Surgery Today / Issue 12/2015
Print ISSN: 0941-1291
Electronic ISSN: 1436-2813
DOI: https://doi.org/10.1007/s00595-015-1117-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Comparing diffusion-weighted imaging and positron emission tomography for pulmonary nodules measuring from 1 to 3 cm in size

Abstract

Purposes

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purposes

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2015

Effect of NF-κB inhibition on chemoresistance in biliary–pancreatic cancer

Early jejunostomy creation in cases of isolated hypoganglionosis: verification of our own experience based on a national survey

Effects of sleeve gastrectomy and gastric banding on the hypothalamic feeding center in an obese rat model

The tumor marker score is an independent predictor of survival in patients with recurrent hepatocellular carcinoma

RETRACTED ARTICLE: Clinical significance of perineural invasion diagnosed by immunohistochemistry with anti-S100 antibody in Stage I-III colorectal cancer

Recent trend of acute appendicitis during pregnancy